CN Bio

Private

CambridgeHealthcare & Life Scienceshttps://cn-bio.com/

Last Round

Series B

Apr 23, 2024

Total Funding Raised

$11.75M

Company Overview

CN Bio is a biotechnology company that develops organ-on-a-chip platforms for drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Biotech Equipment, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

Organ-on-a-ChipOOCmicrophysiological systemsMPSdrug discovery platformpreclinical testingalternative to animal testingcontract research servicesCRSdisease modelingADME profilingtoxicology testinglab-on-a-chip3D cell culturein vitro modelsin silico modelingPBPK modeling

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CN Bio Comps

Public and private peers based on sector, stage, and business model.

CN Bio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CN Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Apr 23, 2024
Grant	Mar 2, 2021
Series A	Mar 2, 2020
Grant	Oct 11, 2017
Seed	Jul 15, 2009

View all Funding Rounds

Key People

Founding team and executive leadership

Paul Brooks

Chief Executive Officer

Executive Team

CN Bio Investors

Notable investors and investment history

CN Bio investors
Investor	Rounds
CITIC Securities Investment Co., Ltd.	Series A
Bayland Capital	Series B
Innovate UK	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 31, 2026
Monthly visitors increased 69% MoM, reaching 15.3K.
Jun 1, 2025
Monthly visitors grew 38% MoM, reaching 9.1K.

View all signals

CN Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

CN Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CN Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge

Employee Range58

Year Founded2008

Last FundingApr 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.